In polycythaemia vera, those patients who have an elevated platelet count develop more thrombotic and more haemorrhagic complications than those with a normal count, even when the haematocrit is maintained by therapy within the normal range.
Introduction
Thrombosis is a common complication of polycythaemia vera and the most frequent cause of death (Chievitz & Thiede, 1962) . The authors of some standard haematological textbooks imply that the raised red blood cell volume is the major contributor to the thrombotic tendency of polycythaemia vera (Miale, 1967; Wintrobe, 1967) and recommendations for therapy take account of this view. De Gruchy (1964) and Britton (1969) , however, consider that a raised platelet count is an additional important cause of thrombosis, and suggest that treatment be also directed to reduction of the number of platelets.
We have examined the case-records of a group of patients with polycythaemia vera in an attempt to assess the relationship of the circulating platelet level to thrombotic and haemorrhagic complications.
Patients and methods
We examined the records of the forty-six patients with polycythaemia vera admitted to the Aberdeen General Hospitals in the last decade who had had at least one platelet count performed. The majority of these patients were treated by at least one of the authors. The diagnosis was made after exclusion of secondary or relative polycythaemia by history, physical examination and conventional blood counts.
In some cases, the red blood cell volume was measured by the use of Fig. 1 .
The mean platelet count of the patients presenting with thrombosis was higher than in those without thrombotic or haemorrhagic complications but this difference was not statistically significant (P > 0.1). shorter. Nine of the eleven deaths resulted from a vascular thrombosis.
Discussion
Increased blood viscosity, secondary to the increase in the haematocrit, is generally considered to be the most important factor in the increased thrombotic tendency of patients with polycythaemia vera. Some believe that an increase in the platelet count may also be important. In the present study of patients with polycythaemia vera we have found that patients with an elevated platelet count developed, in the months and years after presentation, substantially more thrombotic complications than those with a normal count. This study, therefore, provides some evidence that a raised platelet count has an important role in the production of thrombotic lesions in polycythaemia vera.
The death-rate in this series was high-eleven out of the forty-six patients died (24%); in only two patients was death not the direct result of thrombosis, and five of these died within a month of presentation. In contrast only one patient developed acute myeloid leukaemia.
In planning therapy for patients with polycythaemia vera, attention has been focused in recent years on the risks of the late development of acute leukaemia as a result of administration of radioactive phosphorus (Perkins, Israels & Wilkinson, 1964; Modan & Lilienfeld, 1965) ; it seems salutary to stress again the more immediate dangers of thrombosis. This study points to the importance of a raised platelet count in the genesis of thrombosis in polycythaemia, and suggests that reduction of the haematocrit should be accompanied by measures directed to control of the platelet count.
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